Clinical Trial Update: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study assessing the bioavailability of Rocatinlimab (AMG 451) when administered via vial versus prefilled syringe in healthy participants has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Rocatinlimab (rocatinlimab)

Snippet

Sponsor: Amgen | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED